Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates

Stroke

Volumn 37, Issue 6, 2006, Pages 1465-1470

  Huttner, Hagen B ^a,d   Schellinger, Peter D ^a,d   Hartmann, Marius ^a   Köhrmann, Martin ^a,d   Juettler, Eric ^a   Wikner, Johannes ^a   Mueller, Stephan ^a   Meyding Lamade, Uta ^a,c   Strobl, Ralf ^b   Mansmann, Ulrich ^b   Schwab, Stefan ^d   Steiner, Thorsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institute of Medical Statistics   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Intracerebral hemorrhage; Outcome; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; VITAMIN K GROUP; WARFARIN; BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX CONCENTRATES;

ADULT; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; BLOOD COMPONENT THERAPY; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; HEMATOMA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PLASMA;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; CEREBRAL HEMORRHAGE; CRITICAL CARE; FEMALE; HEMATOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLASMA; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VITAMIN K;

EID: 33745141580     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000221786.81354.d6     Document Type: Article

References (30)

1. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
2. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-884.
3. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995;26:1471-1477.
4. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
5. Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J. Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant- related intracerebral hemorrhage. Stroke. 2000;31:2558-2562.
6. Gebel JM, Sila CA, Sloan MA, Granger CB, Weisenberger JP, Green CL, Topol EJ, Mahaffey KW. Comparison of the abc/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the gusto-1 trial. Stroke. 1998;29:1799-1801.
7. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J. The abcs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305.
8. Huttner HB, Steiner T, Hartmann M, Kohrmann M, Juettler E, Mueller S, Wikner J, Meyding-Lamade U, Schramm P, Schwab S, Schellinger PD. Comparison of abc/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke. 2006;37:404-408.
9. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783-1787.
10. Yasaka M, Minematsu K, Naritomi H, Sakata T, Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost. 2003;89:278-283.
11. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-1064.
12. Boulis NM, Bobek MP, Schmaier A, Hoff JT Use of factor ix complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999;45:1113-1118; discussion 1118-1119.
13. Guidelines on oral anticoagulation: third edition. Br J Haematol. 1998;101:374-387.
14. Hanley JP. Warfarin reversal. J Clin Pathol. 2004;57:1132-1139.
15. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 1999;30:765-768.
16. Hart RG. What causes intracerebral hemorrhage during warfarin therapy? Neurology. 2000;55:907-908.
17. Rosand J, Hylek EM, O'Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology. 2000;55:947-951.
18. Butler AC, Tait RC. Management of oral anticoagulant-induced intracranial hemorrhage. Blood Rev. 1998;12:35-44.
19. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke. 1992;23:972-977.
20. Sjoblom L, Hardemark HG, Lindgren A, Norrving B, Fahlen M, Samuelsson M, Stigendal L, Stockelberg D, Taghavi A, Wallrup L, Wallvik J. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke. 2001;32:2567-2574.
21. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37:256-262.
22. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997;77:477-480.
23. Goldstein JN, Thomas SH, Frontiero V, Joseph A, Engel C, Snider R, Smith EE, Greenberg SM, Rosand J. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke. 2006;37:151-155.
24. Nilsson OG, Lindgren A, Brandt L, Saveland H. Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg. 2002;97:531-536.
25. Zurasky JA, Aiyagari V, Zazulia AR, Shackelford A, Diringer MN. Early mortality following spontaneous intracerebral hemorrhage. Neurology. 2005;64:725-727.
26. Daverat P, Castel JP, Dartigues JF, Orgogozo JM. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke. 1991;22:1-6.
27. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
28. Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG Jr, Czervionke LF, Meschia JF. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc. 2004;79:1495-1500.
29. Park P, Fewel ME, Garton HJ, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery. 2003;53:34-38.
30. Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med. 2002;137:884-888.